Abstract
Recently, a new classification algorithm (CA) for systemic necrotizing vasculitides was proposed by Watts et al. (Annals Rheum Dis 66:222–227, 2007) by using the American College of Rheumatology (ACR), Chapel Hill Consensus Criteria (CHCC) and Sorensen surrogate markers (So). We aimed to validate CA in our patients. One hundred twenty-nine patients followed up in our vasculitis clinic were reclassified according to CA in different categories (ACR or Lanham criteria in “1” for Churg–Strauss Syndrome (CSS); ACR in “2a”; CHCC-Wegener's granulomatosis (WG) in “2b”; CHCC-microscopic polyangiitis (MPA), So-WG in “2c”; So-WG, proteinase 3 (PR3) or myeloperoxidase antineutrophil cytoplasmic antibody (MPO ANCA) serology in “2d” for WG; clinical features and histology compatible with small vessel vasculitis without So-WG in “3a”; So-MPA, PR3 or MPO ANCA serology in “3b” for MPA; CHCC-classic-polyarteritis nodosa (c-PAN) or typical angiographic features in “4” for c-PAN; unclassifiable in “5”). Kappa statistic was used to analyse the agreement of the criteria that formed the algorithm. All of 12 CSS, 91% of 69 WG, 78% of 18 MPA and 93% of 26 c-PAN patients remained in their previous diagnosis. WG patients were placed in 2a (83%), 2c (3%), 2d (14%) categories. Four WG (6%) and four MPA (22%) patients were categorized as MPA (in 3a (75%), 3b (25%)) and WG (in 2c (75%), 2d (25%)), respectively. Three of four unclassified patients could be classified as c-PAN (two) and MPA (one). Significant agreement was demonstrated only for ACR and So criteria in WG (κ = 0.62, p < 0.001). The majority of our patients stayed on their previous diagnosis in “CA”. Our findings suggest that this algorithm is helpful and practical for epidemiological studies. Poor correlation of defined criteria was thought to be related to the fact that each criteria mainly consist of different characteristics of vasculitides such as clinical, histopathological and serological features.
Similar content being viewed by others
References
Zeek PM (1952) Periarteritis nodosa—a clinical review. Am J Clin Pathol 22:777–790
van der Woude FJ, Rasmussen N, Lobatto S et al (1985) Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 23:425–429
Leavitt RY, Fauci AS, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33:1101–1107
Masi AT, Hunder GG, Lie JT et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg–Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094–1100
Lightfood RW, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33:1088–1094
Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides. Proposal of an international concensus conference. Arthritis Rheum 37:187–192
Sorensen SF, Slot O, Tvede N, Petersen J (2000) A prospective study of vasculitis patients collected in 5 year period: evaluation of the Chapell Hill nomenclature. Ann Rheum Dis 59:478–482
Watts R, Lane S, Hanslik T et al (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222–227
Bruce IN, Bell AL (1997) A comparison of two nomenclature systems for primary systemic vasculitis. Br J Rheumatol 36:453–458
Liu LJ, Chen M, Yu F, Zhao MH, Wang HY (2008) Evaluation of a new algorithm in classification of systemic vasculitis. Rheumatology 47:708–712
Tzelepis GE, Kokosi M, Tzioufas A et al (2010) Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J 36:116–121
Manganelli P, Fietta P, Carotti M, Pesci A, Salaffi F (2006) Respiratory system involvement in systemic vasculitides. Clin Exp Rheumatol 24(Suppl 41):48–59
Franssen CF, Stegeman CA, Kallenberg CG et al (2000) Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int 57:2195–2206
Jayne DR, Rasmussen N (1997) Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group. Mayo Clin Proc 72:737–747
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kamali, S., Artim-Esen, B., Erer, B. et al. Re-evaluation of 129 patients with systemic necrotizing vasculitides by using classification algorithm according to consensus methodology. Clin Rheumatol 31, 325–328 (2012). https://doi.org/10.1007/s10067-011-1793-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-011-1793-3